How to buy PLx Pharma stock (PLXP)

PLx Pharma is a pharmaceuticals business based in the US. PLx Pharma shares (PLXP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. PLx Pharma employs 16 staff and has a trailing 12-month revenue of around $4.5 million.

Our top picks for where to buy PLx Pharma stock

Buy PLx Pharma stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

PLx Pharma stock price (NASDAQ: PLXP)

Use our graph to track the performance of PLXP stocks over time.

PLx Pharma shares at a glance

• Key figures

Information last updated 2024-06-30.

Latest market close	$0.00
52-week range	$0.00 - $0.00
50-day moving average more info button	$0.14
200-day moving average more info button	$0.56
Wall St. target price	$11.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-0.39

Is it a good time to buy PLx Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PLx Pharma price performance over time

Historical closes compared with the close of $0.004 from 2023-06-14

1 week (2024-10-03)	N/A
1 month (2024-09-10)	N/A
3 months (2024-07-10)	N/A
6 months (2024-04-10)	N/A

1 year (2023-10-10)	N/A
2 years (2022-10-14)	-99.28%
3 years (2021-10-14)	13.54
5 years (2019-10-14)	4.785

PLx Pharma financials

Revenue TTM	$4.5 million
Gross profit TTM	$3.4 million
Return on assets TTM	-64.39%
Return on equity TTM	-75.18%
Profit margin	0%
Book value	$0.35
Market Capitalization more info button	$2.5 million

TTM: trailing 12 months

PLx Pharma share dividends

We're not expecting PLx Pharma to pay a dividend over the next 12 months.

Have PLx Pharma's shares ever split?

PLx Pharma's shares were split on a 1:8 basis on 19 April 2017. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PLx Pharma shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for PLx Pharma shares which in turn could have impacted PLx Pharma's share price.

PLx Pharma share price volatility

Over the last 12 months, PLx Pharma's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PLx Pharma's is 3.9197. This would suggest that PLx Pharma's shares are significantly more volatile than the average for this exchange and represent a higher risk.

PLx Pharma overview

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

Frequently asked questions

What percentage of PLx Pharma is owned by insiders or institutions?
Currently 15.391% of PLx Pharma shares are held by insiders and 23.255% by institutions. How many people work for PLx Pharma?
Latest data suggests 16 work at PLx Pharma. When does the fiscal year end for PLx Pharma?
PLx Pharma's fiscal year ends in December. Where is PLx Pharma based?
PLx Pharma's address is: 9 Fishers Lane, Sparta, NJ, United States, 07871 What is PLx Pharma's ISIN number?
PLx Pharma's international securities identification number is: US72942A1079 What is PLx Pharma's CUSIP number?
PLx Pharma's Committee on Uniform Securities Identification Procedures number is: 25456J104